At-risk genomic findings for pediatric-onset disorders from genome sequencing vs medically actionable gene panel in proactive screening of newborns and children

J Balciuniene, R Liu, L Bean, F Guo… - JAMA Network …, 2023 - jamanetwork.com
Importance Although the clinical utility of genome sequencing for critically ill children is well
recognized, its utility for proactive pediatric screening is not well explored. Objective To …
被引用次数：4 相关文章

At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and …

J Balciuniene, R Liu, L Bean, F Guo… - JAMA Network …, 2023 - search.ebscohost.com
Abstract Key Points: Question: Is there a clinical value of screening ostensibly healthy
newborns and children with genome sequencing in comparison with a gene panel for …

At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and …

J Balciuniene, R Liu, L Bean, F Guo… - JAMA network …, 2023 - pubmed.ncbi.nlm.nih.gov
Importance Although the clinical utility of genome sequencing for critically ill children is well
recognized, its utility for proactive pediatric screening is not well explored. Objective To …
[HTML] nih.gov

[HTML][HTML] At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns …

J Balciuniene, R Liu, L Bean, F Guo… - JAMA Network …, 2023 - ncbi.nlm.nih.gov
At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs
Medically Actionable Gene Panel in Proactive Screening of Newborns and Children - PMC …